Tag:
QRxPharma
Latest Headlines
Latest Headlines
Pain tablet has sustained-release pharmacokinetic profile
QRxPharma has announced the results of a Phase I trial for MoxDuo CR, a controlled-release Dual-Opioid designed to provide 12 hours of pain relief in patients suffering from moderate to severe
